Brivanib ;
BMS-540215 ;
(1R)-2-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo [2,1-f] [1,2,4]triazin-6-yl]oxy]-1-methylethanol ;
CAS # 649735-46-6 ;
C19H19FN4O3 ;
MW: 370.38 ;
Brivanib ;
BMS-540215 ;
(1R)-2-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo [2,1-f] [1,2,4]triazin-6-yl]oxy]-1-methylethanol ;
CAS # 649735-46-6 ;
C19H19FN4O3 ;
MW: 370.38 ;